Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Dmochowski

Showing results (101-110 of 184) with videos related to

Pageof 19
Sort By:
Neurourology and Urodynamics|February 8, 2013
OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivityEric Rovner, Roger Dmochowski, Christopher Chapple, et al.
Neurourology and Urodynamics|August 18, 2017
Reviewing the ICS 2002 terminology report: The ongoing debatePaul Abrams, Walter Artibani, Linda Cardozo, et al.
Urology|March 18, 2008
Fesoterodine dose response in subjects with overactive bladder syndromeVik Khullar, Eric S Rovner, Roger Dmochowski, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|May 13, 2009
Patient-reported most bothersome symptoms in OAB: post hoc analysis of data from a large, open-label trial of solifenacinPeter K Sand, William D Steers, Roger Dmochowski, et al.
Neurourology and Urodynamics|April 8, 2009
Reviewing the ICS 2002 terminology report: the ongoing debatePaul Abrams, Walter Artibani, Linda Cardozo, et al.
Urology Practice|August 18, 2023
Recent Antibiotic Treatment Increases the Risk of Urinary Tract Infection after Outpatient CystoscopyJustin R Gregg, Caroline Lai, Roger Dmochowski, et al.
Clinical Therapeutics|June 11, 2013
Psychometric performance of the incontinence quality-of-life questionnaire among patients with overactive bladder and urinary incontinenceDonald L Patrick, Kristin M Khalaf, Roger Dmochowski, et al.
European Urology Open Science|November 29, 2023
The Effects of Age, Gender, and Postvoid Residual Volume on Catheterization Rates After Treatment with OnabotulinumtoxinA for Overactive BladderRoger Dmochowski, Christopher Chapple, Jennifer Gruenenfelder, et al.
The Journal of Urology|April 15, 2018
Efficacy and Safety of SER120 Nasal Spray in Patients with Nocturia: Pooled Analysis of 2 Randomized, Double-Blind, Placebo Controlled, Phase 3 TrialsJed Kaminetsky, Seymour Fein, Roger Dmochowski, et al.
Neurourology and Urodynamics|November 3, 2017
What was hot at ICS 2016?William Gibson, Alison J Hainsworth, Samantha J Morris, et al.
Pageof 19

Showing results (101-110 of 184) with videos related to

Sort By:
Pageof 19
Neurourology and Urodynamics|February 8, 2013
OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivityEric Rovner, Roger Dmochowski, Christopher Chapple, et al.
Neurourology and Urodynamics|August 18, 2017
Reviewing the ICS 2002 terminology report: The ongoing debatePaul Abrams, Walter Artibani, Linda Cardozo, et al.
Urology|March 18, 2008
Fesoterodine dose response in subjects with overactive bladder syndromeVik Khullar, Eric S Rovner, Roger Dmochowski, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|May 13, 2009
Patient-reported most bothersome symptoms in OAB: post hoc analysis of data from a large, open-label trial of solifenacinPeter K Sand, William D Steers, Roger Dmochowski, et al.
Neurourology and Urodynamics|April 8, 2009
Reviewing the ICS 2002 terminology report: the ongoing debatePaul Abrams, Walter Artibani, Linda Cardozo, et al.
Urology Practice|August 18, 2023
Recent Antibiotic Treatment Increases the Risk of Urinary Tract Infection after Outpatient CystoscopyJustin R Gregg, Caroline Lai, Roger Dmochowski, et al.
Clinical Therapeutics|June 11, 2013
Psychometric performance of the incontinence quality-of-life questionnaire among patients with overactive bladder and urinary incontinenceDonald L Patrick, Kristin M Khalaf, Roger Dmochowski, et al.
European Urology Open Science|November 29, 2023
The Effects of Age, Gender, and Postvoid Residual Volume on Catheterization Rates After Treatment with OnabotulinumtoxinA for Overactive BladderRoger Dmochowski, Christopher Chapple, Jennifer Gruenenfelder, et al.
The Journal of Urology|April 15, 2018
Efficacy and Safety of SER120 Nasal Spray in Patients with Nocturia: Pooled Analysis of 2 Randomized, Double-Blind, Placebo Controlled, Phase 3 TrialsJed Kaminetsky, Seymour Fein, Roger Dmochowski, et al.
Neurourology and Urodynamics|November 3, 2017
What was hot at ICS 2016?William Gibson, Alison J Hainsworth, Samantha J Morris, et al.
Pageof 19